Cleary Gottlieb has advised Viking Global Investors. Gibson Dunn has advised Damora Therapeutics. The acquisition of Damora Therapeutics Inc. by Galecto Inc. was completed alongside a...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP and Walkers (Cayman) LLP have advised MoonLake Immunotherapeutics. Mintz has advised Leerink Partners. MoonLake Immunotherapeutics has completed the pricing of an...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP has advised X4 Pharmaceuticals, and Freshfields US LLP has advised the underwriters. Dechert LLP has served as special counsel for X4...
You must be a Standard 1 Year member to access this content.
Cooley has advised Electra Therapeutics, and Gibson Dunn has advised Nextech Ventures and EQT Life Sciences. Electra Therapeutics, a clinical-stage biotechnology company focused on developing therapies...
You must be a Standard 1 Year member to access this content.
Gibson Dunn has advised XOMA Royalty Corporation, and Duane Morris has advised H.C. Wainwright & Co., LLC. XOMA Royalty Corporation has established an at-the-market facility allowing...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher has advised XOMA Royalty Corporation, and Duane Morris LLP has advised Leerink Partners LLC. XOMA Royalty Corporation has established two at-the-market facilities,...
You must be a Standard 1 Year member to access this content.
Sidley Austin has advised Roche, and Gibson, Dunn & Crutcher LLP has advised 89bio, Inc. Roche has entered into a definitive merger agreement to acquire 89bio,...
You must be a Standard 1 Year member to access this content.
Gibson Dunn and Goodwin Procter has advised Dianthus Therapeutics, Inc., while Cooley has represented the underwriters. Dianthus Therapeutics, Inc., a clinical-stage biotechnology company focused on antibody...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP and Loyens & Loeff N.V. have advised XOMA Royalty Corporation on the transaction, while Cooley LLP and NautaDutilh N.V. as its...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz has advised STAAR Surgical Company. Gibson, Dunn & Crutcher LLP has advised Alcon. STAAR Surgical Company, a manufacturer of proprietary Implantable...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP has advised US WorldMeds on the transaction, and Ropes & Gray LLP has advised Adaptimmune Therapeutics plc. US WorldMeds has entered...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher is advising Immedica Pharma AB on the transaction and Hogan Lovells is advising Marinus Pharmaceuticals, Inc. Immedica Pharma AB (Immedica), a leading...
You must be a Standard 1 Year member to access this content.
